ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/08/19 | 1,644 | 1,677 | 1,629 | 1,665 | +17 | +1% | 633,000 |
| 2024/08/16 | 1,580 | 1,654 | 1,577 | 1,648 | +92 | +5.9% | 1,104,500 |
| 2024/08/15 | 1,565 | 1,571 | 1,545 | 1,556 | +6 | +0.4% | 506,400 |
| 2024/08/14 | 1,585 | 1,586 | 1,534 | 1,550 | -12 | -0.8% | 862,300 |
| 2024/08/13 | 1,502 | 1,582 | 1,495 | 1,562 | +71 | +4.8% | 984,900 |
| 2024/08/09 | 1,518 | 1,523 | 1,473 | 1,491 | +3 | +0.2% | 704,100 |
| 2024/08/08 | 1,474 | 1,507 | 1,466 | 1,488 | +10 | +0.7% | 586,800 |
| 2024/08/07 | 1,425 | 1,507 | 1,404 | 1,478 | +24 | +1.7% | 1,071,600 |
| 2024/08/06 | 1,421 | 1,474 | 1,413 | 1,454 | +75 | +5.4% | 2,163,600 |
| 2024/08/05 | 1,479 | 1,528 | 1,343 | 1,379 | -180 | -11.5% | 2,189,700 |
| 2024/08/02 | 1,643 | 1,660 | 1,550 | 1,559 | -104 | -6.3% | 1,534,000 |
| 2024/08/01 | 1,682 | 1,690 | 1,647 | 1,663 | -17 | -1% | 605,900 |
| 2024/07/31 | 1,696 | 1,701 | 1,642 | 1,680 | -22 | -1.3% | 617,000 |
| 2024/07/30 | 1,691 | 1,709 | 1,678 | 1,702 | +9 | +0.5% | 913,700 |
| 2024/07/29 | 1,695 | 1,702 | 1,683 | 1,693 | +3 | +0.2% | 499,100 |
| 2024/07/26 | 1,687 | 1,703 | 1,668 | 1,690 | +3 | +0.2% | 629,200 |
| 2024/07/25 | 1,703 | 1,726 | 1,683 | 1,687 | -17 | -1% | 1,519,600 |
| 2024/07/24 | 1,645 | 1,754 | 1,645 | 1,704 | +59 | +3.6% | 1,733,600 |
| 2024/07/23 | 1,630 | 1,656 | 1,625 | 1,645 | +8 | +0.5% | 387,800 |
| 2024/07/22 | 1,627 | 1,641 | 1,606 | 1,637 | +17 | +1% | 440,100 |
| 2024/07/19 | 1,640 | 1,649 | 1,620 | 1,620 | -14 | -0.9% | 399,900 |
| 2024/07/18 | 1,660 | 1,696 | 1,619 | 1,634 | -36 | -2.2% | 945,800 |
| 2024/07/17 | 1,665 | 1,684 | 1,663 | 1,670 | +21 | +1.3% | 458,300 |
| 2024/07/16 | 1,669 | 1,684 | 1,646 | 1,649 | -31 | -1.8% | 709,700 |
| 2024/07/12 | 1,638 | 1,690 | 1,634 | 1,680 | +25 | +1.5% | 915,500 |
| 2024/07/11 | 1,677 | 1,677 | 1,633 | 1,655 | -12 | -0.7% | 749,000 |
| 2024/07/10 | 1,692 | 1,700 | 1,653 | 1,667 | -13 | -0.8% | 739,300 |
| 2024/07/09 | 1,633 | 1,681 | 1,632 | 1,680 | +61 | +3.8% | 976,900 |
| 2024/07/08 | 1,622 | 1,638 | 1,613 | 1,619 | +11 | +0.7% | 330,600 |
| 2024/07/05 | 1,625 | 1,638 | 1,605 | 1,608 | +3 | +0.2% | 351,400 |
| 2024/07/04 | 1,642 | 1,646 | 1,605 | 1,605 | -36 | -2.2% | 412,900 |
| 2024/07/03 | 1,590 | 1,641 | 1,590 | 1,641 | +62 | +3.9% | 681,800 |
| 2024/07/02 | 1,565 | 1,586 | 1,562 | 1,579 | +11 | +0.7% | 487,200 |
| 2024/07/01 | 1,607 | 1,609 | 1,561 | 1,568 | -35 | -2.2% | 590,300 |
| 2024/06/28 | 1,609 | 1,615 | 1,600 | 1,603 | -9 | -0.6% | 464,600 |
| 2024/06/27 | 1,621 | 1,671 | 1,609 | 1,612 | +7 | +0.4% | 1,240,400 |
| 2024/06/26 | 1,580 | 1,639 | 1,578 | 1,605 | +17 | +1.1% | 859,500 |
| 2024/06/25 | 1,566 | 1,601 | 1,566 | 1,588 | +42 | +2.7% | 757,600 |
| 2024/06/24 | 1,518 | 1,562 | 1,511 | 1,546 | +39 | +2.6% | 572,800 |
| 2024/06/21 | 1,519 | 1,540 | 1,506 | 1,507 | -12 | -0.8% | 389,700 |
| 2024/06/20 | 1,495 | 1,527 | 1,494 | 1,519 | +24 | +1.6% | 386,700 |
| 2024/06/19 | 1,526 | 1,533 | 1,488 | 1,495 | -24 | -1.6% | 505,900 |
| 2024/06/18 | 1,535 | 1,545 | 1,519 | 1,519 | -13 | -0.8% | 320,500 |
| 2024/06/17 | 1,523 | 1,534 | 1,498 | 1,532 | -1 | -0.1% | 456,600 |
| 2024/06/14 | 1,527 | 1,550 | 1,521 | 1,533 | -2 | -0.1% | 466,500 |
| 2024/06/13 | 1,566 | 1,566 | 1,520 | 1,535 | -28 | -1.8% | 433,700 |
| 2024/06/12 | 1,533 | 1,572 | 1,515 | 1,563 | +18 | +1.2% | 838,000 |
| 2024/06/11 | 1,516 | 1,559 | 1,513 | 1,545 | +28 | +1.8% | 961,600 |
| 2024/06/10 | 1,522 | 1,528 | 1,496 | 1,517 | +3 | +0.2% | 410,200 |
| 2024/06/07 | 1,502 | 1,521 | 1,486 | 1,514 | +12 | +0.8% | 448,200 |
201～
250
件表示中 / 5111件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 92,000円 | +20.3% | - | 0.00% | 163.12倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 148,400円 | -2.4% | -52.3% | 3.84% | 17.76倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 220,000円 | +4.1% | -3.1% | 2.64% | 19.16倍 | 1.67倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ＪＣＲファーマ | 55,400円 | +14.3% | - | 3.61% | 22.50倍 | 1.44倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| あすかＨＤ | 233,000円 | +16.9% | +33.2% | 2.36% | 12.71倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
